Affordable Access

A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis.

Authors
Type
Published Article
Journal
Ophthalmology
0161-6420
Publisher
Elsevier
Publication Date
Volume
107
Issue
8
Pages
1512–1517
Identifiers
PMID: 10919900
Source
Medline
License
Unknown

Abstract

Topical ketorolac 0.5% used four times daily is no better than artificial tears at relieving the symptoms or signs of viral conjunctivitis and produces more stinging than artificial tears.

Statistics

Seen <100 times